PAZOPANIB vs PEGFILGRASTIM-BMEZ: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PAZOPANIB vs PEGFILGRASTIM-BMEZ: Safety Overview
| Metric | PAZOPANIB | PEGFILGRASTIM-BMEZ |
|---|---|---|
| Total FAERS Reports | 21,208 | 399 |
| Deaths Reported | 5,612 | 144 |
| Death Rate | 26.5% | 36.1% |
| Hospitalizations | 4,347 | 117 |
| Average Patient Age | 61.2 yrs | 57.3 yrs |
| % Female Patients | 41.2% | 55.8% |
| FDA Approval Date | Apr 23, 2024 | N/A |
| Manufacturer | Golden State Medical Supply, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Prescription |